Abstract

CD8+ T cell differentiation into effector cells is initiated early after antigen encounter by signals from the T cell antigen receptor and costimulatory molecules. The molecular mechanisms that establish the timing and rate of differentiation however are not defined. Here we show that the RNA binding proteins (RBP) ZFP36 and ZFP36L1 limit the rate of differentiation of activated naïve CD8+ T cells and the potency of the resulting cytotoxic lymphocytes. The RBP function in an early and short temporal window to enforce dependency on costimulation via CD28 for full T cell activation and effector differentiation by directly binding mRNA of NF-κB, Irf8 and Notch1 transcription factors and cytokines, including Il2. Their absence in T cells, or the adoptive transfer of small numbers of CD8+ T cells lacking the RBP, promotes resilience to influenza A virus infection without immunopathology. These findings highlight ZFP36 and ZFP36L1 as nodes for the integration of the early T cell activation signals controlling the speed and quality of the CD8+ T cell response.

RNA binding proteins (RBP) have a function in T cell activation and differentiation. Here the authors show that in the absence of two RBPs, ZFP36 and ZFP36L1, T cells acquire more rapidly superior effector capabilities, showing a limiting function for RBP in T cell activation and differentiation.

Details

Title
The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins
Author
Petkau Georg 1 ; Mitchell, Twm J 1 ; Chakraborty Krishnendu 1 ; Bell, Sarah E 1   VIAFID ORCID Logo  ; D´Angeli Vanessa 1 ; Matheson, Louise 1   VIAFID ORCID Logo  ; Turner, David J 1 ; Saveliev, Alexander 1   VIAFID ORCID Logo  ; Gizlenci Ozge 1   VIAFID ORCID Logo  ; Salerno Fiamma 1   VIAFID ORCID Logo  ; Katsikis, Peter D 2   VIAFID ORCID Logo  ; Turner, Martin 1   VIAFID ORCID Logo 

 Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777) 
 Erasmus University Medical Center, Department of Immunology, Rotterdam, Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2655924778
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.